Health News
FDA Focus on TNF Blockers
A class of drugs is now under suspicion of causing cancer in children, adolescents and young adults under the age of 30. These are called Tumor Necrosis Factor (TNF) blockers, and the U.S. Food and Drug Administration (FDA) recently released an update regarding its ongoing safety review of these drugs.
Psoriasis Drugs Not Linked to Cardiovascular Problems
Early reports indicating drugs treating psoriasis were linked to major cardiovascular events seem to lack evidence.